Vi-CRM(197) as a new conjugate vaccine against Salmonella Typhi

An efficacious, low cost vaccine against typhoid fever, especially for young children, would make a major impact on disease burden in developing countries. The virulence capsular polysaccharide of Salmonella Typhi (Vi) coupled to recombinant mutant Pseudomonas aeruginosa exoprotein A (Vi-rEPA) has b...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Micoli, F., Rondini, S., Pisoni, I., Proietti, D., Berti, F., Costantino, P., Rappuoli, R., Szu, S., Saul, A., Martin, L.B.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4163788/
https://ncbi.nlm.nih.gov/pubmed/21115057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2010.11.022
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items